Sarepta Therapeutics (SRPT) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -95.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.23% |
| Dec 31, 2025 | -90.57% |
| Sep 30, 2025 | -38.45% |
| Jun 30, 2025 | 9.01% |
| Mar 31, 2025 | 34.54% |
| Dec 31, 2024 | 100.02% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 62.86% |
| Mar 31, 2024 | 242.06% |
| Dec 31, 2023 | 139.06% |
| Sep 30, 2023 | 260.50% |
| Jun 30, 2023 | 97.28% |
| Mar 31, 2023 | 70.87% |
| Dec 31, 2022 | 261.02% |
| Sep 30, 2022 | -10.93% |
| Jun 30, 2022 | 54.02% |
| Mar 31, 2022 | -73.75% |
| Dec 31, 2021 | -92.29% |
| Sep 30, 2021 | -63.48% |
| Jun 30, 2021 | -69.25% |
| Mar 31, 2021 | 131.90% |
| Dec 31, 2020 | 65.79% |
| Sep 30, 2020 | 168.35% |
| Jun 30, 2020 | 14.91% |
| Mar 31, 2020 | -43.92% |
| Dec 31, 2019 | -14.58% |
| Sep 30, 2019 | -53.07% |
| Jun 30, 2019 | 91.81% |
| Mar 31, 2019 | 33.68% |
| Dec 31, 2018 | 418.16% |
| Sep 30, 2018 | 2,526.27% |
| Jun 30, 2018 | 202.93% |
| Mar 31, 2018 | 172.47% |
| Dec 31, 2017 | 33.80% |
| Sep 30, 2017 | -8.93% |
| Jun 30, 2017 | 585.20% |
| Mar 31, 2017 | 282.28% |
| Dec 31, 2016 | 168.57% |
| Sep 30, 2016 | -26.77% |
| Jun 30, 2016 | -34.22% |
| Mar 31, 2016 | 119.55% |
| Dec 31, 2015 | -65.43% |
| Sep 30, 2015 | -90.80% |
| Jun 30, 2015 | -85.89% |
| Mar 31, 2015 | -90.01% |
| Dec 31, 2014 | 416.28% |
| Sep 30, 2014 | 839.26% |
| Jun 30, 2014 | 959.86% |
| Mar 31, 2014 | 59,077.78% |
| Sep 30, 2013 | 3,891.43% |
| Jun 30, 2013 | 217.91% |
| Mar 31, 2013 | 0.00% |
| Sep 30, 2012 | -111.78% |
| Jun 30, 2012 | -70.16% |
| Mar 31, 2012 | -96.04% |
| Dec 31, 2011 | 0.49% |
| Sep 30, 2011 | 3.13% |